Updates on managing augmentation in RLS from Sleep Europe 2024
Dopaminergic medications have been widely used in the treatment of restless legs syndrome (RLS), where they are effective at reducing symptoms in the short term. However, long-term use of these agents has been associated with augmentation, a worsening of symptoms over time or earlier in the day. This phenomenon has led to a shift in treatment recommendations, favoring non-dopaminergic options as first-line therapies.
This podcast brings you updates on managing augmentation in RLS from Sleep Europe 2024, which took place in Seville, Spain. You will hear from experts Celia Garcia-Malo, MD, PhD…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.